Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut Microbiota in Cancer Immune Response and Immunotherapy
Cheng‐Bei Zhou, Yilu Zhou, Jing‐Yuan Fang
Trends in cancer (2021) Vol. 7, Iss. 7, pp. 647-660
Closed Access | Times Cited: 208

Showing 1-25 of 208 citing articles:

The microbiota-gut-brain axis in sleep disorders
Zhe Wang, Zhong Wang, Tangsheng Lu, et al.
Sleep Medicine Reviews (2022) Vol. 65, pp. 101691-101691
Closed Access | Times Cited: 128
Crosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and Immunotherapy
Connor Campbell, Mrunmayee Kandalgaonkar, Rachel M. Golonka, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 294-294
Open Access | Times Cited: 110
Advances in immunotherapy for triple-negative breast cancer
Yang Liu, Yueting Hu, Jinqi Xue, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 108
Akkermansia muciniphila and Faecalibacterium prausnitzii in Immune-Related Diseases
Raden Mohamad Rendy Ariezal Effendi, Muhammad Anshory, Handono Kalim, et al.
Microorganisms (2022) Vol. 10, Iss. 12, pp. 2382-2382
Open Access | Times Cited: 75
Drug-microbiota interactions: an emerging priority for precision medicine
Qing Zhao, Yao Chen, Weihua Huang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 73
Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor–induced colitis
Taylor M. Halsey, Anusha Shirwaikar Thomas, Tomo Hayase, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 700
Closed Access | Times Cited: 60
A major mechanism for immunomodulation: Dietary fibres and acid metabolites
Liang Xie, Jahangir Alam, Francine Z. Marques, et al.
Seminars in Immunology (2023) Vol. 66, pp. 101737-101737
Open Access | Times Cited: 47
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
Ashley M. Holder, Aikaterini Dedeilia, Kailan Sierra-Davidson, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 7, pp. 498-512
Closed Access | Times Cited: 45
Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target
Mengwei Zhang, Jinkai Liu, Qiang Xia
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 44
Vitamin D regulates microbiome-dependent cancer immunity
Evangelos Giampazolias, Mariana Pereira da Costa, Khiem C. Lam, et al.
Science (2024) Vol. 384, Iss. 6694, pp. 428-437
Open Access | Times Cited: 40
Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies
Jindong Xie, Manqing Liu, Xinpei Deng, et al.
iMeta (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 31
Gut microbiome affects the response to immunotherapy in non‐small cell lung cancer
Shengnan Ren, Lingxin Feng, Haoran Liu, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 14, pp. 1149-1163
Open Access | Times Cited: 17
Fecal microbiota transplantation: no longer cinderella in tumour immunotherapy
Yunwei Yang, Yaping An, Yue Dong, et al.
EBioMedicine (2024) Vol. 100, pp. 104967-104967
Open Access | Times Cited: 16
Effect of radiotherapy exposure on fruquintinib plus sintilimab treatment in refractory microsatellite stable metastatic colorectal cancer: a prospective observation study
Mingxia Cheng, Min Jin, Shengli Yang, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e009415-e009415
Open Access | Times Cited: 2
Gut Microbiota-Derived Metabolites in Colorectal Cancer: The Bad and the Challenges
Wanru Zhang, Yaping An, Xiali Qin, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 70
Extensive Summary of the Important Roles of Indole Propionic Acid, a Gut Microbial Metabolite in Host Health and Disease
Hui Jiang, Congying Chen, Jun Gao
Nutrients (2022) Vol. 15, Iss. 1, pp. 151-151
Open Access | Times Cited: 57
Cancer as microenvironmental, systemic and environmental diseases: opportunity for transdisciplinary microbiomics science
Kentaro Inamura, Tsuyoshi Hamada, Susan Bullman, et al.
Gut (2022) Vol. 71, Iss. 10, pp. 2107-2122
Open Access | Times Cited: 50
Stress and cancer: The mechanisms of immune dysregulation and management
Yixin Liu, Sheng Tian, Biao Ning, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 48
Coprophagy Prevention Affects the Reproductive Performance in New Zealand White Rabbits Is Mediated through Nox4-ROS-NFκB Pathway
Zhichao Li, Ruiting Li, Jing Li, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 38
Multi-kingdom gut microbiota analyses define bacterial-fungal interplay and microbial markers of pan-cancer immunotherapy across cohorts
Xiaowen Huang, Muni Hu, Tiantian Sun, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 11, pp. 1930-1943.e4
Open Access | Times Cited: 37
Bioactive polysaccharides promote gut immunity via different ways
Xincheng Wu, Xiaojun Huang, Wanning Ma, et al.
Food & Function (2023) Vol. 14, Iss. 3, pp. 1387-1400
Closed Access | Times Cited: 30
Bacteria-based immunotherapy for cancer: a systematic review of preclinical studies
Min Zhou, Yucheng Tang, Wenjie Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 29
Four Ounces Can Move a Thousand Pounds: The Enormous Value of Nanomaterials in Tumor Immunotherapy
Ziyin Chen, Ziqi Yue, Kaiqi Yang, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 26
Open Access | Times Cited: 27
Gut microbiota mediated the individualized efficacy of Temozolomide via immunomodulation in glioma
Xiaoying Hou, Hongzhi Du, Yufei Deng, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 25
The Efficacy of Tumor Mutation Burden as a Biomarker of Response to Immune Checkpoint Inhibitors
Camille Moeckel, Katrina Bakhl, Ilias Georgakopoulos-Soares, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6710-6710
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top